Why the study?
Does propafenone reduce ventricular premature complexes and ventricular tachycardia in patients with chronic ventricular arrhythmias?
Population
Patients with chronic ventricular arrhythmias, including ventricular premature complexes and ventricular…
Comparison
Propafenone vs Conventional antiarrhythmic agents or control
Design
Review, double-blind (for the 3 U.S. studies reviewed)
Authors
Loading...
Supports propafenone for ventricular arrhythmia suppression; leaves open confirmation in randomized trials.
Does propafenone reduce ventricular premature complexes and ventricular tachycardia in patients with chronic ventricular arrhythmias?
Propafenone is an effective and well-tolerated antiarrhythmic agent for suppressing chronic ventricular arrhythmias, including those refractory to conventional therapies.
Dinh et al. (1986) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: